Credit Agricole’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.2M Sell
625,798
-286,074
-31% -$40.1M 0.23% 77
2025
Q4
$112M Buy
911,872
+204,743
+29% +$24.9M 0.25% 72
2025
Q3
$78.5M Buy
+707,129
New +$80.4M 0.21% 83
2025
Q1
$55.3M Sell
493,653
-162,103
-25% -$16.7M 0.17% 107
2024
Q4
$60.6M Buy
655,756
+453,737
+225% +$40.9M 0.18% 96
2024
Q3
$16.9M Sell
202,019
-133,495
-40% -$10.2M 0.07% 195
2024
Q2
$23M Buy
335,514
+237,980
+244% +$15.9M 0.12% 129
2024
Q1
$6.45M Buy
97,534
+55,793
+134% +$4.29M 0.07% 224
2023
Q4
$3.38M Buy
41,741
+16,264
+64% +$1.27M 0.04% 253
2023
Q3
$1.91M Buy
25,477
+21,844
+601% +$1.68M 0.03% 281
2023
Q2
$280K Sell
3,633
-75
-2% -$5.98K 0.01% 403
2023
Q1
$308K Buy
3,708
+170
+5% +$14.1K 0.01% 362
2022
Q4
$304K Sell
3,538
-10,298
-74% -$816K 0.01% 383
2022
Q3
$854K Sell
13,836
-20,490
-60% -$1.29M 0.02% 308
2022
Q2
$2.12M Sell
34,326
-3,330
-9% -$206K 0.05% 242
2022
Q1
$2.24M Buy
37,656
+725
+2% +$46.3K 0.04% 243
2021
Q4
$2.68M Sell
36,931
-1,996
-5% -$137K 0.04% 219
2021
Q3
$2.72M Sell
38,927
-14,325
-27% -$1.01M 0.05% 211
2021
Q2
$3.67M Buy
53,252
+1,044
+2% +$69.7K 0.08% 179
2021
Q1
$3.38M Sell
52,208
-22,444
-30% -$1.45M 0.09% 164
2020
Q4
$4.35M Buy
74,652
+46,450
+165% +$2.8M 0.14% 125
2020
Q3
$1.78M Sell
28,202
-20,112
-42% -$1.39M 0.1% 157
2020
Q2
$3.72M Buy
48,314
+5,555
+13% +$426K 0.24% 94
2020
Q1
$3.2M Buy
42,759
+6,282
+17% +$434K 0.27% 91
2019
Q4
$2.37M Buy
36,477
+7,599
+26% +$495K 0.13% 123
2019
Q3
$1.83M Buy
28,878
+5,830
+25% +$381K 0.09% 168
2019
Q2
$1.56M Buy
23,048
+4,050
+21% +$266K 0.08% 171
2019
Q1
$1.24M Sell
18,998
-55,524
-75% -$3.69M 0.07% 244
2018
Q4
$4.66M Buy
74,522
+2,550
+4% +$178K 0.26% 93
2018
Q3
$5.56M Buy
71,972
+48,546
+207% +$3.67M 0.27% 91
2018
Q2
$1.66M Buy
23,426
+500
+2% +$35.3K 0.12% 170
2018
Q1
$1.73M Buy
22,926
+2,290
+11% +$182K 0.12% 153
2017
Q4
$1.48M Sell
20,636
-2,184,455
-99% -$166M 0.1% 180
2017
Q3
$179M Sell
2,205,091
-76,140
-3% -$5.82M 0.61% 29
2017
Q2
$161M Buy
2,281,231
+1,357,607
+147% +$90.3M 0.53% 37
2017
Q1
$62.7M Sell
923,624
-591,876
-39% -$41.6M 0.19% 135
2016
Q4
$109M Buy
1,515,500
+159,553
+12% +$11.9M 0.35% 65
2016
Q3
$107M Buy
1,355,947
+143,282
+12% +$11.6M 0.35% 57
2016
Q2
$101M Sell
1,212,665
-504,427
-29% -$44.8M 0.39% 52
2016
Q1
$158M Buy
1,717,092
+336,759
+24% +$30.4M 0.75% 24
2015
Q4
$140M Buy
1,380,333
+132,630
+11% +$13.8M 0.65% 27
2015
Q3
$123M Buy
1,247,703
+193,685
+18% +$21.5M 0.61% 29
2015
Q2
$123M Sell
1,054,018
-334,416
-24% -$36.5M 0.58% 29
2015
Q1
$136M Sell
1,388,434
-517,129
-27% -$52.5M 0.61% 27
2014
Q4
$190M Buy
1,905,563
+77,887
+4% +$8.06M 0.81% 17
2014
Q3
$195M Buy
1,827,676
+105,181
+6% +$10.3M 0.83% 15
2014
Q2
$143M Sell
1,722,495
-229,295
-12% -$17.8M 0.6% 18
2014
Q1
$138M Buy
1,951,790
+634,380
+48% +$49.8M 0.56% 26
2013
Q4
$98.9M Buy
1,317,410
+362,824
+38% +$25.3M 0.41% 52
2013
Q3
$60M Buy
+954,586
New +$57.1M 0.26% 88

Other funds holding GILD

Credit Agricole's GILD Position: Q1 2026 in Review

Credit Agricole reduced its Gilead Sciences (GILD) stake by 31% in Q1 2026, selling an estimated $40.1M and leaving 625,798 shares worth $87.2M. The position accounts for 0.23% of the portfolio, ranked #77.

Credit Agricole first reported a position in GILD in Q3 2013 and has held it in 50 quarters since. The position peaked at $195M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Credit Agricole held 625,798 shares of Gilead Sciences worth $87.2M as of Q1 2026.
  • Credit Agricole sold 286,074 Gilead Sciences shares in Q1 2026, an estimated $40.1M.
  • Gilead Sciences made up 0.23% of Credit Agricole's portfolio in Q1 2026, its #77 holding.
  • Credit Agricole first reported a position in Gilead Sciences in Q3 2013 and has held it in 50 quarters since.
  • Credit Agricole's Gilead Sciences position peaked at $195M in Q3 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.